Veracyte, Inc. VCYT
Set alert
50.59 USD +1.59 +3.24%
As of Nov 3, 10:54 AM ET
49.88 Day range 51.07
29.46 52-week range 60.91
- YTD
- +20.17%
- 1 year
- +38.79%
- Open
- 49.95
- Prev close
- 49.00
- Mkt cap
- 4.07B
- Vol
- 102.54K
- Avg vol
- 1.30M
- EPS
- 1.40
- P/E
- 36.14
- Div yield
- 0.00%
More statistics
- Low
- 49.88
- High
- 51.07
- Forward P/E
- 25.22
- Beta
- 1.96
- Short ratio
- 6.64
- Inst. own
- 115.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 44.42
- 200-d avg
- 42.82
- 1y target
- 59.73
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 59.73 +18.1% upside
Now 50.59
- Target (low)
- 45.00
- Target (mean)
- 59.73
- Target (high)
- 70.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
- Strong buy2
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 13
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.40973 | 0.35 – 0.45 | 0.51 | -19.7% | 147.16M | +11.6% | 11 |
| Next quarter | 0.44563 | 0.36 – 0.50 | 0.53 | -15.9% | 157.29M | +11.8% | 11 |
| Current year | 1.91 | 1.78 – 1.99 | 1.78 | +7.2% | 593.80M | +14.8% | 11 |
| Next year | 1.94 | 1.67 – 2.11 | 1.91 | +1.8% | 660.07M | +11.2% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 2026 | Freedom Capital Markets | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 31, 2026 | Needham | Maintained | Buy | Buy |
| Jul 30, 2026 | Needham | Maintained | Buy | Buy |
| Jul 15, 2026 | Piper Sandler | Initiated | Overweight | Overweight |
| Jul 14, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 9, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 1, 2026 | Needham | Maintained | Buy | Buy |
| May 28, 2026 | Needham | Reiterated | Buy | Buy |
| May 6, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| May 6, 2026 | UBS | Maintained | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Apr 13, 2026 | Jefferies | Initiated | — | Buy |
| Apr 1, 2026 | Needham | Maintained | Buy | Buy |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 6, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Feb 26, 2026 | Needham | Maintained | Buy | Buy |
| Jan 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 2, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Nov 11, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Nov 5, 2025 | UBS | Maintained | Buy | Buy |
| Nov 5, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Nov 5, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 5, 2025 | Needham | Maintained | Buy | Buy |
| Oct 20, 2025 | Canaccord Genuity | Initiated | — | Hold |
